Ravinandan A P

Abstract

 

View Article

Abstract

Dapagliflozin which is also known as Farxiga in the US and Forxiga in the EU is a drug which was developed by Bristol-Myers Squibb in partnership with Astra Zeneca. It is also available in Oxra and it is marking by Sun Pharmaceutical Industries Ltd. It contains the active substance Dapagliflozin which is the second member of selective sodium glucose co-transporter-2 (SGLT-2) inhibitor and it is the first group among oral anti-diabetic agents which are independent of insulin secretion. The drug Dapagliflozin shows the action of reducing the blood glucose by preventing the reabsorption of glucose at the renal proximal tubule and avoids insulin resistance. It is a new molecule that helps in maintaining the glycemic control either in mono therapy or combinational therapy or add on therapy. This is a review article which summarizes the details of plozaDaglifin. Keywords: Type­2 Diabetes Mellitus, Dapagliflozin, Selective Sodium Glucose Co­ Transporter­2 (SGLT­2) Inhibitor

View Article

Abstract

Background: A prescription is a written order to provide instructions regarding patient medications by the physician. Prescription include directions for the pharmacist to dispense the medication, directions for the patient regarding administration of drugs. Patient demographics and prescriber details are the legal requirements of the prescription writing. Materials and Methods: An observational study was conducted and data collection forms were used to collect the information from the patient. Confidentiality was maintained to secure the patient information, prescription details, throughout the study. All the prescriptions are analyzed for general details, medical components, and legal requirements. The data obtained were summed up and simple statistical analysis was performed to draw the results. All the prescriptions had general details mentioned in it. Result: The mentioning of demographic details in prescription were found to be 48.07%. Result: The clarity of the prescription related to legibility of handwriting was achieved in 92.24%. Poly-therapy was observed in 73 prescriptions. Most of the prescriptions did not provided description on the direction on usage of medications. Conclusion: Our study highlights the need to train prescribing doctors on writing rational prescriptions for quality improvement.   Keywords: Prescription, quality, Legal requirements, Rational prescriptions, Observational

View Article